Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Automatic gas control versus manual low-flow sevoflurane anesthesia during pancreaticoduodenectomy
PACTR202008584308152Phase 4Completed
- Sponsor
- Eman Therapeutics
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sevoflurane (2 arms), sponsored by Eman Therapeutics. Primary endpoint: Effect of automatic gas control on sevoflurane gas monitoring parameters. Started Mar 2020; status: completed.
02
Drugs
sevoflurane
Beyond the preview
Go deeper on PACTR202008584308152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202008584308152.